ZYMEWORKS INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ZYMEWORKS INC. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $3.21M, a 131.55% increase year-over-year.
- ZYMEWORKS INC. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $8.72M, a 1030.61% increase year-over-year.
- ZYMEWORKS INC. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $8.56M, a 64.44% increase year-over-year.
- ZYMEWORKS INC. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $1.39M, a 21.81% increase year-over-year.
- ZYMEWORKS INC. stock issued during period, value, stock options exercised for fiscal 2025 was $17.75M, a 93.28% increase from fiscal 2024.
- ZYMEWORKS INC. stock issued during period, value, stock options exercised for fiscal 2024 was $9.18M, a 75.83% increase from fiscal 2023.
- ZYMEWORKS INC. stock issued during period, value, stock options exercised for fiscal 2023 was $5.22M, a 1765.00% increase from fiscal 2022.
- ZYMEWORKS INC. stock issued during period, value, stock options exercised for fiscal 2022 was $280.00K, a 97.10% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $3.21M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $8.72M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $17.75M 10-K · filed 2026-03-02 | |
| 2025-09-30 | $8.56M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $1.39M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $771.00K 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $9.18M 10-K · filed 2026-03-02 | |
| 2024-09-30 | $5.21M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $1.14M 10-Q · filed 2025-11-06 | |
| 2024-03-31 | $1.96M 10-Q · filed 2025-11-06 | |
| 2023-12-31 | $5.22M 10-K · filed 2026-03-02 | |
| 2023-09-30 | $1.33M 10-Q · filed 2024-10-31 | |
| 2023-06-30 | $1.43M 10-Q · filed 2024-10-31 | |
| 2023-03-31 | $1.65M 10-Q · filed 2024-10-31 | |
| 2022-12-31 | $280.00K 10-K · filed 2025-03-05 | |
| 2022-09-30 | $107.00K 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $7.00K 10-Q · filed 2023-11-07 | |
| 2022-03-31 | $12.00K 10-Q · filed 2023-11-07 | |
| 2021-12-31 | $9.66M 10-K · filed 2024-03-06 | |
| 2021-09-30 | $5.94M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $763.00K 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $1.96M 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $15.43M 10-K · filed 2023-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |